Pulmatrix (PULM) Cash from Financing Activities (2013 - 2026)

Pulmatrix (PULM) posted Cash from Financing Activities of $1.0 million for Q1 2026, up 1786.79% sequentially from $53000.0 in Q1 2023.

Pulmatrix (PULM) Cash from Financing Activities (2013 - 2026) Analysis & Trends

Pulmatrix has reported Cash from Financing Activities for 12 years, with the latest figure at $1.0 million in Q1 2026.

Quarterly Cash from Financing Activities changed N/A year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (changed N/A YoY) and the FY2023 annual result came in at $53000.0, down 95.69% from the prior year.
Cash from Financing Activities improved to $1.0 million in Q1 2026 per PULM's latest filing, from $53000.0 in the prior quarter.
Over five years, Cash from Financing Activities peaked at $1.4 million in Q3 2022 and troughed at -$152000.0 in Q1 2022.
A 3-year average of $570750.0 and a median of $526500.0 in 2023 frame the typical range for Cash from Financing Activities.
The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities plunged 100.41% in 2022, then soared 134.87% in 2023.
Over 3 years, Cash from Financing Activities stood at $1.4 million in 2022, then tumbled by 96.16% to $53000.0 in 2023, then surged by 1786.79% to $1.0 million in 2026.
According to Business Quant data, Cash from Financing Activities over the past three periods registered $1.0 million, $53000.0, and $1.4 million for Q1 2026, Q1 2023, and Q3 2022 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Financing Activities (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-426.70 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-1.22 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	14.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-6.05 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	36.24 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-16.65 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	27.18 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-273.15 Mn
10	Pulmatrix	5.46 Mn	5.46 Mn	-	-50,000.00

Download Data